Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: A systematic review
International Forum of Allergy & Rhinology Jan 29, 2020
Larivée N, et al. - Because aspirin-exacerbated respiratory disease (AERD) is an aggressive form of chronic rhinosinusitis with nasal polyposis that is notoriously difficult to treat and there is evidence to suggest desensitization to aspirin may improve symptomatology and disease control in these patients, researchers sought to critically assess the literature on this topic and evaluate the impact of desensitization on sinonasal symptomatology. EMBASE, CINAHL, MEDLINE, and the Cochrane Library for relevant literature were searched. Twenty-four studies had met the criteria for inclusion. Overall, polyp size, polyp recurrence, nasal symptom scores, sense of smell, number of acute episodes of rhinosinusitis, and systemic use of steroids improved when desensitized patients. The vast majority of investigations suggest desensitization. There is mounting evidence that in the treatment of patients with AERD, aspirin desensitization is a valuable adjunct to treat sinonasal symptoms.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries